Literature DB >> 6653624

The role of embolization in the treatment of kidney carcinoma.

A V Bono, A Caresano.   

Abstract

Although embolization is widely employed in kidney cancer patients, it is not yet clearly understood whether the procedure may influence the natural history of the disease. The writers' experience consists of 99 embolized patients, performed since 1976. The effects of the procedure were reduction of tumor bulk, creation of a good edematous cleavage plane, and shrinkage of venous thrombi. In stage I and II cases embolization seems to have prolonged the survival times of patients who died of tumor, but in stage III and IV cases no difference can be detected between the embolized and nonembolized groups, whereas in stage IV cases only palliative surgery allows better survival times.

Entities:  

Mesh:

Year:  1983        PMID: 6653624     DOI: 10.1159/000474117

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  5 in total

1.  Utilization of interventional oncology treatments in the United States.

Authors:  Sharon W Kwan; Robert K Kerlan; Jonathan H Sunshine
Journal:  J Vasc Interv Radiol       Date:  2010-05-15       Impact factor: 3.464

2.  Embolization of nonliver visceral tumors.

Authors:  Paul G Thacker; Jeremy L Friese; Matthew Loe; Peter Biegler; Michael Larson; James Andrews
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

Review 3.  Role of embolization in the treatment of renal masses.

Authors:  David Li; Bradley B Pua; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

Review 4.  Arterial embolization in patients with renal carcinoma.

Authors:  S W Christensen; J Berg; S Brynitz; M S Rasmussen
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

5.  Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy.

Authors:  Sung Han Kim; Jung Kwon Kim; Boram Park; Jungnam Joo; Jae Young Joung; Ho Kyung Seo; Kang Hyun Lee; Jinsoo Chung
Journal:  Oncotarget       Date:  2017-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.